Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001513162-20-000010
Filing Date
2020-01-09
Accepted
2020-01-09 16:17:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 424(B)(3) 424b3.htm 424B3 45668
  Complete submission text file 0001513162-20-000010.txt   46811
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 424B3 | Act: 33 | File No.: 333-227653 | Film No.: 20518370
SIC: 8071 Services-Medical Laboratories